Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Diken M, Attig S, Grunwitz C, Kranz L, Simon P, van de Roemer N, Vascotto F, Kreiter S. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany. Hum Vaccin Immunother 2013;9:2025-32. [PMID: 23877042 PMCID: PMC3906376 DOI: 10.4161/hv.25768] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open

For:	Diken M, Attig S, Grunwitz C, Kranz L, Simon P, van de Roemer N, Vascotto F, Kreiter S. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany. Hum Vaccin Immunother 2013;9:2025-32. [PMID: 23877042 PMCID: PMC3906376 DOI: 10.4161/hv.25768] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open

Number

Cited by Other Article(s)

Kranz LM, Birtel M, Krienke C, Grunwitz C, Petschenka J, Reuter KC, van de Roemer N, Vascotto F, Vormehr M, Kreiter S, Diken M. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy. Hum Vaccin Immunother 2015;12:213-21. [PMID: 26186022 PMCID: PMC4962731 DOI: 10.1080/21645515.2015.1068485] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Accepted: 06/29/2015] [Indexed: 12/22/2022] Open

Affiliation(s)

Lena M Kranz TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany Research Center for Immunotherapy (FZI); University Medical Center; Johannes Gutenberg University; Mainz, Germany
Matthias Birtel TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany
Christina Krienke TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany Research Center for Immunotherapy (FZI); University Medical Center; Johannes Gutenberg University; Mainz, Germany
Christian Grunwitz TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany BioNTech RNA Pharmaceuticals GmbH; Mainz, Germany
Jutta Petschenka TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany
Kerstin C Reuter BioNTech RNA Pharmaceuticals GmbH; Mainz, Germany
Niels van de Roemer TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany Research Center for Immunotherapy (FZI); University Medical Center; Johannes Gutenberg University; Mainz, Germany
Fulvia Vascotto TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany
Mathias Vormehr TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany BioNTech RNA Pharmaceuticals GmbH; Mainz, Germany
Sebastian Kreiter TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany
Mustafa Diken TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH; Mainz, Germany

Collapse